Effective biologics against all pandemic-potential pathogens
Panoplia was started by a team of scientists and engineers to expand the reach and impact of broad-spectrum medicines for infectious diseases. Panoplia’s mission is to reduce pandemic threats by creating broad-spectrum antivirals. We focus on developing inhalable antivirals that provide extended prophylaxis, remain dormant until infection, and target the most conserved viral properties.
Our Team
-
Brian Wang
Executive Director
-
Joe Torres
Program Lead
-
Kenza Samlali
Product Developer
-
Alex Norman
Scientist
-
Alex Kleinman
Scientist
Our Board
Aleš Flídr (Chair), Jacob Swett (Treasurer), Will Bradshaw (Secretary)
We are supported by
How you can help.
Partner with us.
We partner with scientific and manufacturing organizations to develop new technologies that align with our mission and out-license technologies for impact.
Donate.
We accept tax-deductible donations through Players Philanthropy Fund, our fiscal sponsor.